ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (1561 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bbamcr.2004.12.009    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2005 Elsevier B.V. All rights reserved.

The plasticity of p19ARF null hepatic stellate cells and the dynamics of activation

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Verena Proell, Mario Mikula, Eva Fuchs and Wolfgang MikulitsCorresponding Author Contact Information, E-mail The Corresponding Author

Department of Medicine I, Division: Institute of Cancer Research, Medical University of Vienna, Borschke-Gasse 8a, A-1090 Vienna, Austria


Received 6 October 2004; 
revised 16 December 2004; 
accepted 20 December 2004. 
Available online 21 January 2005.

Abstract

In the healthy adult liver, quiescent hepatic stellate cells (HSCs) present the major site for vitamin A storage in cytoplasmic lipid droplets. During liver injury due to viral infection or alcohol intoxication, HSCs get activated and produce high amounts of extracellular matrix components for tissue repair and fibrogenesis. Employing p19ARF deficiency, we established a non-transformed murine HSC model to investigate their plasticity and the dynamics of HSC activation. Primary HSCs isolated from livers of adult p19ARF null mice underwent spontaneous activation through long-term passaging without an obvious replicative limit. The immortalized cell line, referred to as M1-4HSC, showed stellate cell characteristics including the expression of desmin, glial fibrillary acidic protein, α-smooth muscle actin and pro-collagen I. Treatment of these non-tumorigenic M1-4HSC with pro-fibrogenic TGF-β1 provoked a morphological transition to a myofibroblastoid cell type which was accompanied by enhanced cellular turnover and impaired migration. In addition, M1-4HSCs expressed constituents of cell adhesion complexes such as p120ctn and β-catenin at cell borders, which dislocalized in the cytoplasm during stimulation to myofibroblasts, pointing to the epitheloid characteristics of HSCs. By virtue of its non-transformed phenotype and unlimited availability of cells, the p19ARF deficient model of activated HSCs and corresponding myofibroblasts render this system a highly valuable tool for studying the cellular and molecular basis of hepatic fibrogenesis.

Keywords: Hepatic stellate cell; TGF-β; Fibrogenesis; Myofibroblast

Article Outline

1. Introduction
2. Materials and methods
2.1. Isolation and immortalization of p19ARF null hepatic stellate cells
2.2. Limiting dilution
2.3. Tumor formation in vivo
2.4. Proliferation kinetics
2.5. Reverse transcription polymerase chain reaction (RT-PCR)
2.6. Western blot analysis
2.7. Transwell assay
2.8. Analysis of caspase-3 activity
2.9. Analysis of cell viability
2.10. Thymidine incorporation
2.11. Confocal immunofluorescence microscopy
3. Results
3.1. Establishment of immortalized p19ARF null hepatic stellate cells (HSCs)
3.2. Single cell clones of M1-4HSCs display again a heterogeneous phenotype
3.3. The fibrogenic factor TGF-β provokes further activation of M1-4HSCs
3.4. Reprogramming of ECM components during activation of HSCs to M-HTs
3.5. The balance between cell division rate and apoptosis is shifted by TGF-β
3.6. The migration of HSCs is reduced by TGF-β
3.7. Cell–cell contact formation of activated mHSCs is affected by TGF-β
4. Discussion
Acknowledgements
References







Corresponding Author Contact InformationCorresponding author. Tel.: +43 1 4277 65250; fax: +43 1 4277 65239.

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.